The Janus Property Company signed a lease with Hemogenyx Pharmaceuticals LLC for 10,000 square feet at the Mink Building in the West Side’s Manhattanville Factory District adjacent to Columbia University and City College. Hemogenyx Pharmaceuticals is a rapidly growing biopharmaceutical innovator transitioning from a pre-clinical to a clinical study-stage business, and is publicly traded on the main market of the London Stock Exchange. The company’s objective is to develop breakthrough therapies for the treatment of blood cancers and autoimmune diseases and to make bone marrow transplantations safer and more accessible to a larger number of patients.
Hemogenyx Pharmaceuticals will be moving to the Mink Building from SUNY Downstate’s campus, becoming the third recent leading life science firm to relocate to the Factory District, following Quentis Therapeutics from Alexandria Center in Kips Bay and Volastra Therapeutics from J Labs in Lower Manhattan. These tenants join Quicksilver Therapeutics, BioBus, Renal Research Institute and a DASNY health facility, bringing the building to approximately 80% leased to life science and health care tenants. This is in addition to Harlem Biospace and Hypothekids that are also tenants in the District. Hemogenyx Pharmaceuticals’ lab will include two clean rooms purpose-built by Janus, allowing it to pursue commercialization of its major cell therapy product candidates, starting with its HEMO-CAR-T cell therapy for the treatment of acute myeloid leukemia.
“We are extremely gratified that Hemogenyx Pharmaceuticals chose the District for its new home,” said Scott Metzner, principal, the Janus Property Company. “It’s wonderful to see the growth of so many different life science options for tenants to grow in or to move to in New York, so we take great pride as so many of today’s most exciting companies are choosing our buildings and our location in such a competitive environment.”
The Mink Building, located on West 126th Street at Amsterdam Avenue, has been completely re-built by Janus while preserving and enhancing the building’s singular industrial charms. The building features expansive ceiling heights and flexible, technology-enabled office and lab settings.
